Search Results 511-520 of 18439 for prednisone

1. A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer - Mayo Clinic

   Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy (prednisone dose > 10 mg per day or equivalent dose) or any other form of ...

2. Trospium (oral route) - Side effects & dosage - Mayo Clinic

   However, elderly patients are more likely to have some unwanted effects (eg, constipation, dry mouth, indigestion, stomach pain, or trouble passing urine) which ...

3. A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma - Mayo Clinic

   ... prednisone equivalent daily) for < 30 days duration. Known history of other malignancy unless having undergone curative intent therapy without evidence of ...

4. Cross-Variant Memory B Cell and T Cell Responses After COVID-19 mRNA Vaccine Booster - Mayo Clinic

   Subjects on corticosteroids will be excluded if ≥ 20mg of Prednisone (or equivalent drug) has been (or will be) administered daily for 2 weeks or more.

5. Frequent bowel movements Causes - Mayo Clinic

   Mucus in stool: A concern? Pituitary tumors and adenomas · Prednisone withdrawal: Why taper down slowly?

6. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Subjects who are currently taking prednisone from a previous prostate cancer therapy will be permitted to enroll in the study. * Receipt of an organ allograft * ...

7. A Study of AP160-Complex in Advanced Solid Tumors - Mayo Clinic

   Patients on chronic corticosteroids for adrenal insufficiency or other reasons may enroll if they receive less than 10 mg/day of prednisone (or equivalent).

8. Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients with High-Risk Stage III-IV Melanoma that has been Removed by Surgery - Mayo Clinic

   ... prednisone, dexamethasone) or continuous use of topical steroid creams or ointments or ophthalmologic steroids; a history of occasional (but not continuous) ...

9. Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma - Mayo Clinic

   insufficiency are eligible if on a stable dose of prednisone =< 10 mg or equivalent - ELIGIBILITY CRITERIA (STEP 1): Patients must not have an uncontrolled ...

10. Mayo-Adimune Collaborative and Programmatic Approach to Tolerization Therapy

    Candidates may not be taking prednisone, cyclosporine, tacrolimus, azathioprine, mycophenolate mofetil, anti-lymphocyte agents, cyclophosphamide ...